← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Calista Therapeutics, Inc.
Lincoln, RI
$697,541
Total funding
3
Grants
Funding over time
peak $248K · FY2013–21$250K$187.5K$125K$62.5K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$697,541 · 3
By mechanism
R43$697,541 · 3
Investigators at Calista Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a selective PI3K-Akt-activating neurotrophic small molecule drug, MT-002, for the healing of corneal wounds in Neurotrophic Keratitis.$247,998
R43 · FY2021 · EY
Therapeutic correction of deltaF508-CFTR cystic fibrosis by a novel PDZ12 drug.$224,993
R43 · FY2013 · HL
Calcaftor, a CFTR stabilizer for Cystic Fibrosis treatment$224,550
R43 · FY2014 · DK